Andere talen Armata Pharmaceuticals, Inc.

Aandelen

ARMP

US04216R1023

Beurs gesloten - Nyse Andere beurzen 22:10:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,76 ^USD	+9,06%		+3,56%	-14,81%

21/03	Armata Pharmaceuticals, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
21/03	Armata Pharmaceuticals, Inc. rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Armata Pharmaceuticals : Shareholder Meeting - Form 8-K	22/03
Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M	21/03
Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Armata Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit	04/03
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update	15/11
Armata Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Armata Pharmaceuticals Announces Presentation of Topline Data from SWARM-P.a. Clinical Study at the North American Cystic Fibrosis Conference	30-10-23
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus	27-09-23
Armata Pharmaceuticals, Inc. Announces First Patient Dosed in the Phase 2A Portion of the Phase 1b/2a 'Disarm' Study of Ap-Sa02 in Adults with Bacteremia Due to Staphylococcus Aureus	26-09-23
Armata Pharmaceuticals to Participate in the Cantor Global Healthcare Conference	22-09-23
Armata Pharmaceuticals, Inc. Announces CFO Changes	20-09-23
Armata Pharmaceuticals, Inc. Announces Executive Changes	20-09-23
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update	15-08-23
Armata Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics	12-07-23
Armata Pharmaceuticals, Inc. Announces That It Has Entered into A Credit and Security Agreement with Innoviva Strategic Opportunities Llc	11-07-23
Armata Pharmaceuticals, Inc. Announces Executive Changes	11-07-23
Armata Pharmaceuticals, Inc. Announces Deborah L. Birx to Board of Directors	11-07-23
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) added to Russell Microcap Value Index	23-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Armata Pharmaceuticals, Inc.

Aandelen

ARMP

US04216R1023

Andere talen

Filters